ISMELIN
LOE ApproachingNDAORALTABLETPriority Review
Approved
Jul 1960
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 8h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ISMELIN is an oral small-molecule antihypertensive agent approved by Novartis in 1960. The drug's specific mechanism of action and therapeutic indications are not fully documented in available data, though its vintage approval and oral tablet formulation suggest use in cardiovascular disease management. It represents a legacy product from the mid-20th century pharmaceutical era.
LOE Approaching
With LOE approaching and zero linked job openings, the commercial team supporting ISMELIN is likely minimal or transitioning resources to newer assets.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
ISMELIN presents minimal career opportunity with zero linked job openings and an LOE-approaching lifecycle. Working on this product would involve managing market decline, ensuring regulatory compliance, and potentially supporting transition activities rather than growth-oriented initiatives.
Legacy Brand ManagerSales Representative (if still actively promoted)
Worked on ISMELIN at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.